• Join
  • Login
  • Contact

Search abstracts

Risk management of celecoxib in FAP indication in Thailand

  • At: 2011 FIP Congress in Hyderabad (India)
  • Type: Poster
  • By: SRIPHIROMYA, Pakawadee (Food and Drug Administration, Nonthaburi, Thailand)
  • Co-author(s): Wechwithan, Sareeya (Food and Drug Administration, Nonthaburi, Thailand)
  • Abstract:

    Introduction: Celecoxib was indicated to reduce the number of adenomatous colorectal polyps for Familial Adenomatous Polyposis (FAP) . The recommended oral dose is 400 mg twice per day. It is  known for risk of serious cardiovascular adverse reactions , especially in high dose. To manage risk of using celecoxib in this indication, Thailand Food


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses